Characterisation of Antisense Oligonucleotides by Ion-Pair Reversed-Phase UHPLC-HRMS: Method development using Design
Antonio Triolo1, Fabiana Tavani1, Prisca Barnini2
1Laboratory of Advanced Analytics, Menarini Ricerche Spa, Florence, Italy.
Developing an ion-pair reversed-phase ultra-high-performance liquid chromatography-high-resolution mass spectrometry (IP-RP-UHPLC-HRMS) method optimizes therapeutic antisense oligonucleotide (ASO) quality control. This approach enhances the detection and characterization of impurities, ensuring API safety and efficacy.
Area of Science:
- Analytical Chemistry
- Pharmaceutical Analysis
- Biotechnology
Background:
- Therapeutic antisense oligonucleotides (ASOs) present analytical challenges in quality control due to complex synthesis and degradation.
- Ensuring the safety and efficacy of active pharmaceutical ingredients (APIs) requires robust analytical methods for ASOs.
Purpose of the Study:
- To develop and optimize an ion-pair reversed-phase ultra-high-performance liquid chromatography-high-resolution mass spectrometry (IP-RP-UHPLC-HRMS) method for therapeutic ASO analysis.
- To establish tailored analytical methods for specific ASOs, fomivirsen (FMV) and tofersen (TFR), using Design of Experiments (DoE).
Main Methods:
- Development of an IP-RP-UHPLC-HRMS method utilizing Orbitrap technology with fomivirsen and tofersen as model compounds.
- Preliminary scouting for optimal ion-pair reagents and MS parameters, followed by Design of Experiments (DoE) for in-depth factor evaluation.
- Multicriteria optimization using response surface methodology to define a 'sweet spot' for method performance.
Main Results:
- Two distinct IP-RP-UHPLC-MS methods were established for FMV and TFR characterization, sharing common mobile phase components and MS parameters.
- All four FMV impurities and 13 out of 15 detected TFR impurities were identified above 0.1% threshold.
- The DoE approach successfully balanced sensitivity and selectivity for ASO impurity analysis.
Conclusions:
- The developed IP-RP-UHPLC-HRMS method provides a structured approach for ASO quality control, meeting regulatory requirements.
- DoE is an effective tool for optimizing analytical procedures for oligonucleotides, tailored to specific compounds and ion-pair agents.
- This work paves the way for more efficient and reliable analytical method development in the pharmaceutical industry for ASOs.
More Related Videos
11:37Protocol for the Solid-phase Synthesis of Oligomers of RNA Containing a 2'-O-thiophenylmethyl Modification and Characterization via Circular Dichroism
Published on: July 28, 2017
09:34Improved Polymerase Chain Reaction-restriction Fragment Length Polymorphism Genotyping of Toxic Pufferfish by Liquid Chromatography/Mass Spectrometry
Published on: September 20, 2016
Related Concept Videos
Ion-Exchange Chromatography
High-Resolution Mass Spectrometry (HRMS)
Peptide Identification Using Tandem Mass Spectrometry
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
Mass Spectrometry: Complex Analysis
GC–MS is a powerful hyphenated method commonly used in forensics and environmental...
MALDI-TOF Mass Spectrometry
